New cell therapy offers effective treatment for patients with T-cell acute lymphoblastic leukemia

A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukaemia (T-ALL) who have exhausted all standard treatment options.

Titan Medical to merge with imaging firm Conavi, ending strategic review

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Imaging company Conavi Medical will

March 19, 2024

Neurocrine gets FDA go-ahead to treat rare adrenal gland condition

A turbulent 2024 for Neurocrine is ending on a high note, after the biotech won FDA approval to treat congenital adrenal hyperplasia, a condition marked

December 17, 2024

Three months after delisting, NGM Bio is back with $122M for slimmed-down pipeline

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.